Finally, DOT1L expression has been correlated with poor patient survival also in human neuroblastoma, a finding confirmed also in mice xenografts, where DOT1L ablation significantly reduced neuroblastoma tumor growth and improved OS (Wong et al., 2017). This evidence concerns the gene DOT1L and neuroblastoma.